Head-to-head · Cost-Efficiency Index
Found vs eMI Aesthetics
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Found
Cost-first shoppers who also want behavior-change coaching bundled with the medication.
Visit FoundeMI Aesthetics
Shoppers wanting compounded sema or tirz in all 50 states with an ai progress simulator.
Visit eMI AestheticsThe verdict
Found takes it, leading the Cost-Efficiency Index 88 to 70. The cheapest identical price on both molecules nationwide — unbeatable raw cost-per-month, capped only by a coaching subscription you can't fully unbundle. eMI Aesthetics still earns a C — Shoppers wanting compounded sema or tirz in all 50 states with an ai progress simulator.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the board). See how it stacks up: CoreAge Rx vs Found.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Found | eMI Aesthetics |
|---|---|---|
| Cost-Efficiency Index | 88/100 | 70/100 |
| Semaglutide / mo | $129/mo | $179/mo (all doses, compounded) |
| Tirzepatide / mo | $129/mo | Not disclosed |
| Semaglutide / yr (modeled) | $1,548 | $2,148 |
| Tirzepatide / yr (modeled) | $1,548 | — |
| Coverage | All 50 states | All 50 states |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Yes |
| Rank on the board | #7 | #97 |
Found
88/100Where the value is
- Lowest cost-per-month on the board — identical $129 on both molecules
- Nationwide
- Strong behavior-change program adds value
The tradeoffs
- Coaching subscription can't be unbundled, which reduces contract flexibility
- Compounded only
eMI Aesthetics
70/100Where the value is
- Available to eligible patients in all 50 states
- Offers both semaglutide and tirzepatide, plus an oral semaglutide option
- Intake and provider visits run through OpenLoop Health, an established telehealth network
The tradeoffs
- Full per-drug pricing is not shown before intake; only an 'as low as 179/month' starting rate is published
- No fill pharmacy or named medical director is publicly listed
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.